BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1576 related articles for article (PubMed ID: 28969413)

  • 21. Transperineal biopsy as a new technique versus well-established transrectal biopsy for diagnosis of prostate cancer - A comparative study.
    Eltafahny A; Alshamlan Y; Almazeedi A; Aldousari S; Salem SM
    Urol Ann; 2024; 16(2):155-159. PubMed ID: 38818431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer detection rate of transrectal ultrasonography, digital rectal examination, and prostate-specific antigen: results of a five-year study of 6- versus 12-core transperineal prostate biopsy.
    Bigliocchi M; Marini M; Nofroni I; Perugia G; Shahabadi H; Ciccariello M
    Minerva Urol Nefrol; 2007 Dec; 59(4):395-402; 403-6. PubMed ID: 17947956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review and meta-analysis of magnetic resonance imaging and ultrasound guided fusion biopsy of prostate for cancer detection-Comparing transrectal with transperineal approaches.
    Loy LM; Lim GH; Leow JJ; Lee CH; Tan TW; Tan CH
    Urol Oncol; 2020 Aug; 38(8):650-660. PubMed ID: 32505458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer.
    Kawakami S; Hyochi N; Yonese J; Yano M; Fujii Y; Kageyama Y; Fukui I; Kihara K
    Int J Clin Oncol; 2006 Apr; 11(2):127-32. PubMed ID: 16622747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the complications of traditional 12 cores transrectal prostate biopsy with image fusion guided transperineal prostate biopsy.
    Huang H; Wang W; Lin T; Zhang Q; Zhao X; Lian H; Guo H
    BMC Urol; 2016 Nov; 16(1):68. PubMed ID: 27855661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study.
    Rakauskas A; Peters M; Martel P; van Rossum PSN; La Rosa S; Meuwly JY; Roth B; Valerio M
    PLoS One; 2023; 18(1):e0280262. PubMed ID: 36652429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: a comparative study of 6 and 12 biopsy cores.
    Takenaka A; Hara R; Hyodo Y; Ishimura T; Sakai Y; Fujioka H; Fujii T; Jo Y; Fujisawa M
    Int J Urol; 2006 Jan; 13(1):10-4. PubMed ID: 16448425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transperineal vs transrectal magnetic resonance and ultrasound image fusion prostate biopsy: a pair-matched comparison.
    Kaneko M; Medina LG; Lenon MSL; Hemal S; Sayegh AS; Jadvar DS; Ramacciotti LS; Paralkar D; Cacciamani GE; Lebastchi AH; Salhia B; Aron M; Hopstone M; Duddalwar V; Palmer SL; Gill IS; Abreu AL
    Sci Rep; 2023 Aug; 13(1):13457. PubMed ID: 37596374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Consensus-based guidelines on prostate biopsy].
    Italian Panel on Prostate Biopsy
    Arch Ital Urol Androl; 2005 Sep; 77(3 Suppl 1):1-2, preceding 1. PubMed ID: 16402723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis.
    Xue J; Qin Z; Cai H; Zhang C; Li X; Xu W; Wang J; Xu Z; Yu B; Xu T; Zou Q
    Oncotarget; 2017 Apr; 8(14):23322-23336. PubMed ID: 28177897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complications of transrectal versus transperineal prostate biopsy.
    Miller J; Perumalla C; Heap G
    ANZ J Surg; 2005; 75(1-2):48-50. PubMed ID: 15740517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
    Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
    BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy.
    Hara R; Jo Y; Fujii T; Kondo N; Yokoyoma T; Miyaji Y; Nagai A
    Urology; 2008 Feb; 71(2):191-5. PubMed ID: 18308081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparametric MRI/TRUS Fusion Prostate Biopsy: Advantages of a Transperineal Approach.
    Pepe P; Garufi A; Priolo GD; Pennisi M
    Anticancer Res; 2017 Jun; 37(6):3291-3294. PubMed ID: 28551679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy in Clinically Significant Prostate Cancer Detection Rate? A Systematic Review and Meta-analysis.
    Uleri A; Baboudjian M; Tedde A; Gallioli A; Long-Depaquit T; Palou J; Basile G; Gaya JM; Sanguedolce F; Lughezzani G; Rajwa P; Pradere B; Roupret M; Briganti A; Ploussard G; Breda A
    Eur Urol Oncol; 2023 Dec; 6(6):621-628. PubMed ID: 37634971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer.
    Israël B; Immerzeel J; van der Leest M; Hannink G; Zámecnik P; Bomers J; Schoots IG; van Basten JP; Debruyne F; van Oort I; Sedelaar M; Barentsz J
    BJU Int; 2022 Apr; 129(4):480-490. PubMed ID: 34358388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer.
    Winoker JS; Wajswol E; Falagario U; Maritini A; Moshier E; Voutsinas N; Knauer CJ; Sfakianos JP; Lewis SC; Taouli BA; Rastinehad AR
    Urology; 2020 Dec; 146():278-286. PubMed ID: 32956688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Prospective Comparison of Transrectal Standard, Cognitive, Transperineal Fusion, and Mapping Prostate Biopsy for Cancer Detection.
    Petov V; Bazarkin A; Morozov A; Taratkin M; Ganzha T; Danilov S; Chernov Y; Chinenov D; Rzayev R; Suvorov A; Amosov A; Fajkovic H; Enikeev D; Krupinov G
    J Endourol; 2023 Aug; 37(8):940-947. PubMed ID: 37294206
    [No Abstract]   [Full Text] [Related]  

  • 39. The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/ml: a randomized study of 6 versus 12 core transperineal prostate biopsy.
    Emiliozzi P; Scarpone P; DePaula F; Pizzo M; Federico G; Pansadoro A; Martini M; Pansadoro V
    J Urol; 2004 Jan; 171(1):197-9. PubMed ID: 14665875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
    Eskicorapci SY; Guliyev F; Akdogan B; Dogan HS; Ergen A; Ozen H
    J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.